Fonar Corporation (FONR)

In the past six months, FONAR Corporation entered a definitive agreement on December 29, 2025, to be acquired by FONAR, LLC and FONAR Acquisition Sub, Inc., led by CEO Timothy Damadian, with shareholders receiving $19.00 per share in cash. Earlier in July 2025, the FONAR board received an initial non-binding "take private" proposal from the CEO-led group at $17.25 per share. FONAR announced its financial results for the first quarter of fiscal 2026 (ended September 30, 2025) on November 10, 2025, reporting a 30% decrease in income from operations and a 33% decrease in consolidated net income compared to the prior year's corresponding quarter.

Specific details on demand seasonality for FONAR Corp.'s products and services were not explicitly found. Analysis of FONR's historical stock price data suggests January has the highest probability of positive returns, while February has a lower probability. Stock price seasonality does not directly equate to demand seasonality for the company's products and services.

FONAR Corporation is a medical technology company specializing in MRI scanners. Founded in 1978, it is the first MRI company, introducing the first commercial MRI in 1980. The company operates through medical equipment and physician management and diagnostic services segments. Its signature product is the FONAR UPRIGHT® Multi-Position™ MRI, which allows patients to be scanned in various weight-bearing positions. The physician management and diagnostic services segment, through HMCA, provides non-medical management services to medical providers and operates diagnostic imaging facilities.

FONAR Corp. markets its MRI systems both domestically and internationally. Its subsidiary, Health Management Corporation of America (HMCA), owns and operates six diagnostic imaging facilities in Florida and manages a total of 44 MRI scanners across New York and Florida. The company's manufacturing and research and development (R&D) operations for its Upright MRI scanners are based in Melville, New York.

FONAR has a long-standing reputation as a pioneer in MRI technology, known for technological advancement, product quality, and customer support. Its signature FONAR UPRIGHT® Multi-Position™ MRI is known for addressing patient comfort and claustrophobia. The "take private" acquisition proposal has been the primary event impacting FONAR's public perception in the past year, with shareholder alert law firms announcing investigations into the proposed buyout.

The ownership structure of FONAR (FONR) stock includes institutional, retail, and individual investors. Approximately 7.84% of the company's stock is owned by institutional investors, 11.82% by insiders, and 80.34% by public companies and individual investors. Major institutional holders include Kayne Anderson Rudnick Investment Management Llc and Money Concepts Capital Corp as of September 30, 2025.